You have successfully logged out.


Coronary Drug Coated Balloon

Best investigated DCB*

In the last 12 years, B. Braun’s SeQuent® Please product family has demonstrated its functionality and efficacy for coronary lesion therapy underlined with a significant clinical evidence portfolio of more than 110 published studies.

SeQuent® Please NEO for coronary angioplasty
Image is temporarily not available.

Clinical evidence

Publications for SeQuent® Please/NEO

The coronary DCB has been investigated in more than 110 studies with over 25,000 documented patients, conducted in more than 20 countries.
All clinical trials at a glance as PDF download

Discover our summaries

Randomized controlled trials

Not randomized controlled trials & observational studies

Related product

Related documents

SeQuent® Please NEO

Clinically proven drug coated balloon catheter

pdf, 1.9 MB

arrow_outward See more

SeQuent® Please NEO – Go Implant-Free!

Safe and effective alternative to DES in de novo lesions

pdf, 27.8 KB

arrow_outward See more

Cardiology Catalog

Your partner for coronary angioplasty

pdf, 1.8 MB

arrow_outward See more

* All numbers referring to clinical coronary trials on PCBs, patients enrolled therein and countries in which these trials were conducted, are based on a PubMed literature search conducted with due diligence in February /March 2022.
(Data on file at B. Braun)

person_outline Attend survey now!